Erlotinib Active Not Recruiting Phase 1 Trials for Pancreatic Adenocarcinoma Metastatic / Stage III Pancreatic Cancer AJCC v6 and v7 / Stage III Pancreatic Cancer / Stage IV Pancreatic Cancer AJCC v6 and v7 / Stage IV Pancreatic Cancer / Recurrent Pancreatic Carcinoma Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01660971Gemcitabine Hydrochloride, Dasatinib, and Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Is Metastatic or Cannot Be Removed by Surgery